Let's focus on the big picture, people.
A clear-cut defense of Nuance.
The biotech produces another quarter of record revenue and earnings.
The company reports record revenue and operating cash flow.
Quarterly revenue increase of 5% isn't enough to satisfy investors.
Third-quarter revenue rises 41.7%, but investigations continue.
They have strong earnings growth and are well off their 52-week highs. Should you buy?
Earnings growth continues, complemented by a big buyback in the third quarter.
The managed-care provider gets rid of what isn't working and builds upon what is.
A Fool's prediction on the FDA's impending decision on approval.
The tobacco company reports a year-over-year increase of 5.9% in Q3 net sales.
Five stocks in the health-care sector that are poised for growth.
The pharmaceutical's net revenue jumps 77%.
The tobacco company reports adjusted EPS growth of 12% versus its year-ago quarter.
Strong operating earnings and membership growth push Aetna shares up.
Bristol-Myers announces a 22% rise in Q3 revenue as Plavix sales continue to rise.
Shares tumble after the FBI raids company HQ.
A Q3 operating revenue increase of 5.2% is just one bit of good news for shareholders.
Zimmer lowers its forecast for the fourth quarter, but reports a solid Q3.
The online jeweler's customer-friendly buying experience has succeeded in making the company a financial success.